Acadia Pharmaceuticals Inc. announced that Doug Williamson, M.D., Executive Vice President, Head of Research and Development, will be leaving the company to pursue other opportunities. Dr. Williamson joined Acadia in January 2023 and will continue in his role during a transitional period. The company has initiated a search for his replacement.
Market Closed -
Other stock markets
|
Pre-market 07:48:06 am | |||
14.89 USD | -2.68% | 14.72 | -1.14% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-52.44% | 2.46B | |
+51.85% | 57.87B | |
+41.53% | 40.25B | |
-5.25% | 39.94B | |
-5.16% | 28.54B | |
+12.79% | 26.4B | |
-20.18% | 19.33B | |
+30.88% | 12.4B | |
+0.61% | 12.23B | |
+25.06% | 12.2B |
- Stock Market
- Equities
- ACAD Stock
- News ACADIA Pharmaceuticals Inc.
- Doug Williamson to Leave ACADIA Pharmaceuticals Inc. as Executive Vice President, Head of Research and Development